CFTR and cystic fibrosis: In this context, ICM was shown to be sensitive to detect improvement of CFTR function when intestinal tissue biopsies were treated with CFTR modulators ex vivo or obtained from patients with CF that were treated systemically with CFTR modulators [43,44,45,46].